You searched for "safety"
Steroid safety in MG treatment
1 October 2019
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
This study was conducted to evaluate the efficacy and safety of low to moderate dose oral steroids in patients diagnosed with ocular myasthenia gravis (MG). This was a retrospective case series. The study reviewed 23 patients; 15 males and eight...
Ranibizumab safety in pregnancy
1 December 2018
| Sofia Rokerya
|
Retina / Uvea / Vitreous
Vascular endothelial growth factor (VEGF) plays a pivotal role during pregnancy, and systemic anti-VEGF administration during this period should thus be avoided. VEGF is expressed in multiple embryonic and foetal tissues during development, with the highest levels found in the...
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
Retina / Uvea / Vitreous
|
Diabetic macular edema (DME), Intravitreal ziv, aflibercept (IVZ), Neovascular age related macular degeneration (n, AMD), Ziv, aflibercept, retinal venous occlusion (RVO)
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
Patient safety – is this achieved in optometry with CET?
1 August 2018
| Janet Pooley
|
EYE - General
Collecting points and ticking boxes – as we come to the end of another three year cycle of continuing education and training (CET), the rush to ensure that everything has been completed on the myGOC (General Optical Council) dashboard feels...
Safety and outcome of microincision vitreous surgery in uveitis
1 June 2018
| Nikolaos D Georgakarakos
|
Retina / Uvea / Vitreous
|
Microincisional vitrectomy, uveitis, vitritis
This paper reports the outcomes of microincision vitreous surgery (MIVS) 23G/25G in uveitis of 103 patients (106 eyes) who underwent diagnostic MIVS over a period of four years at the Advanced Eye centre in Chandigarth India. The postoperative evaluation included...
Review of efficacy and safety of tetracaine drops in strabismus surgery
31 May 2024
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
Tetracaine is a topical anaesthetic drug used to anesthetise the eye and surrounding areas during strabismus surgery. It is generally safe and well tolerated but can cause mild adverse reactions at the site of use and, in rare cases, serious...
Efficacy and safety of intravitreal faricimab in nAMD, DME and RVO
30 January 2025
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This paper is an analysis of data extracted from 13 eligible studies in the context of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), collected from systematic literature search of MEDLINE, Embase, and Cochrane...
Retrospective safety assessment of apraclonidine for diagnosis of Horner’s syndrome in children
2 August 2022
| Lauren R Hepworth
|
Paediatric Ophthalmology / Strabismus
Apraclonidine has been shown to reverse the anisocoria in Horner’s syndrome, with some reports of partial ptosis resolution. Side-effects of apraclonidine have been reported especially in children under six months old. The authors present a retrospective safety study of using...
Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration
1 June 2015
| Jonathan Chan
|
Retina / Uvea / Vitreous
|
Angiogenesis, Clinical Trial, Macula, neovascularisation, Retina
This is a sub-group study of double masked review of patients randomised to different dosages and treatment frequency compared between aflibercept and ranibizumab treatment. This is to evaluate the efficacy and safety of intravitreal aflibercept (IVT-AFL) in Japanese patients with...
One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management
1 August 2018
| Sofia Rokerya
|
EYE - Glaucoma
The authors report a retrospective, non-randomised interventional case series of 39 patients who underwent a standalone XEN45 implantation. All 39 patients (female: male=1.2: 1) completed 12-month follow-up. Mean age was 70.1 years (range 32–92). Primary outcome measures were the intraocular...
Changing the post cataract surgery review pathway – is patient safety compromised?
Cataract surgery continues to be the most commonly performed elective surgical procedure in the UK, with an annual rate of approximately 4150/100,000 people over the age of 65 accounting for a significant proportion of the surgical workload of most ophthalmologists...Efficacy and safety of novel PF brimonidine / timolol fixed-combination ophthalmic solution for OAG
4 August 2021
| Su Young
|
EYE - Glaucoma
|
Open-angle glaucoma, brimonidine/timolol fixed combination, intraocular pressure, normal-tension glaucoma, preservative-free
This study is a multicentre, randomised, open-label, parallel-group clinical trial to evaluate the efficacy and safety of a newly developed preservative-free (PF) brimonidine / timolol fixed-combination (BTFC) ophthalmic solutions as compared with preservative-containing (PC) BTFC ophthalmic solution in adult patients...